reference/12253637

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12253637

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	1271
issn	0300-7995 1473-4877
issueIdentifier	6
pageRange	1263-1271
publicationName	Current Medical Research and Opinion
startingPage	1263
bibliographicCitation	Signorovitch JE, Wu EQ, Betts KA, Parikh K, Kantor E, Guo A, Bollu VK, Williams D, Wei LJ, DeAngelo DJ. Comparative efficacy of nilotinib and dasatinib in newly diagnosed chronic myeloid leukemia: a matching-adjusted indirect comparison of randomized trials. Current Medical Research and Opinion. 2011 Apr 28;27(6):1263–71. doi: 10.1185/03007995.2011.576238.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7069ec9237c26aadc7b6de242d5e8411 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5885a7385b0695fe27e2229f9d305b60 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b2f92d6cbc5f020454bfd6ac42c7762c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_69ae0ea5584b79e203284b8eb8f7855b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e39a34b1849b300977f1fd79e6c15b0d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_308d2eb0b3ffcc4f4582e6b6d82a53dc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7dc11d1af821004fb272a2520eee57f6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fa9c2c3164e532f1ab11f6a52a0359a3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2ff824766b59be8f0d7de11f2cacc5cf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d35dfc12b2a4746794b817dfcd512b86
date	2011-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1185/03007995.2011.576238 https://pubmed.ncbi.nlm.nih.gov/21524239
isPartOf	https://portal.issn.org/resource/ISSN/0300-7995 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3218 https://portal.issn.org/resource/ISSN/1473-4877
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Comparative efficacy of nilotinib and dasatinib in newly diagnosed chronic myeloid leukemia: a matching-adjusted indirect comparison of randomized trials
discusses	http://id.nlm.nih.gov/mesh/M0482811 http://id.nlm.nih.gov/mesh/M0470497 http://id.nlm.nih.gov/mesh/M0018260 http://id.nlm.nih.gov/mesh/M0021333 http://id.nlm.nih.gov/mesh/M0017888 http://id.nlm.nih.gov/mesh/M0001483
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D013844Q000627 http://id.nlm.nih.gov/mesh/D011743Q000627 http://id.nlm.nih.gov/mesh/D015464Q000188 http://id.nlm.nih.gov/mesh/D011505Q000037 http://id.nlm.nih.gov/mesh/D000970Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D000069439 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3062316 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9727 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644241

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247851103 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129879136 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128433595

Total number of triples: 53.